Clinical Trials Logo

Clinical Trial Summary

As the quality of life improves, people are seeking to look as young as they feel. Ginkgo biloba (GB) and Pomegranate (PG) extract can be used to create efficacious topical anti-aging products. GB & PG are now widely used in research and clinical trials on age-associated diseases, for example, skin aging, brain dysfunction, cardiovascular system diseases, carcinogen metabolism. The investigator's aim is to formulate a topical cream in the form (O/W or W/O emulsion) formulation, containing GB as an anti-aging formulation for the public.


Clinical Trial Description

In this study, a vanishing cream will be prepared by reaction of a stearic acid with alkali (NaOH) to form stearate soap. Then the GB extract will be added to the final form. The formulated cream will be characterized for identifying the type of emulsion, calibration curve for GB, drug content, irritation to skin, homogeneity test, pH, FT-IR test, ex vivo studies, physical stability, and human application. Finally, a 9-questions questionnaire was published using Google forms for the human volunteers. ;


Study Design


Related Conditions & MeSH terms

  • Skin and Subcutaneous Tissue Disorders

NCT number NCT03772418
Study type Interventional
Source Al-Azhar University
Contact Ahmed AH Abdellatif, Ph.D.
Phone +966507726856
Email a.abdellatif@qu.edu.sa
Status Recruiting
Phase Phase 1
Start date May 18, 2018
Completion date February 28, 2020

See also
  Status Clinical Trial Phase
Completed NCT02544165 - Non Invasive Measurement of the Haemodynamic Parameters and of the Advanced Glycation End Products (AGEs) Levels N/A